Status:
COMPLETED
Remote Assessment of Physical Function
Lead Sponsor:
University of New Mexico
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Cancer Survivors
Eligibility:
All Genders
60+ years
Brief Summary
The primary objective is to evaluate the validity and reliability of using videoconferencing to assess physical performance tests self-administered by older cancer survivors in their own homes. This r...
Detailed Description
The ultimate goal of this research study is to develop a test protocol to allow older cancer survivors to self-administer physical performance tests in the survivor's own home, while an investigator r...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Residence in New Mexico
- Previous diagnosis of cancer, completed primary treatment (surgery, radiation, chemotherapy), and not currently being treated for a recurrence.
- Mild-to-moderate physical functional impairment (≥2 functions limited a lot or limited a little on the Short Form 36-item Physical Function Subscale)
- Able to speak, read, \& understand English
- Participating in less than 120 minutes per week of moderate-to-vigorous intensity physical activity
- Living independently and capable of walking 3 blocks without stopping to rest.
- Availability of a family member or friend to be present (for safety) during remote assessment of performance tests (Phases III and IV only)
- No severe impairments or pre-existing medical limitations for engaging in daily light-intensity physical activity (e.g., severe orthopedic conditions, pending hip/knee replacement, chronic vertigo, dementia)
- No severe hearing or vision deficits that would inhibit communication with the research team via videoconferencing and tablet use.
- Willing to use a tablet computer and videoconferencing software to communicate with a study team member during the assessment.
- Enough space (14 feet by 3 feet) to safely conduct the physical function tests.
- Not at high risk for falls
Exclusion
Key Trial Info
Start Date :
November 20 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 13 2021
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT04339959
Start Date
November 20 2019
End Date
November 13 2021
Last Update
May 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of New Mexico
Albuquerque, New Mexico, United States, 87131